statistiche ricercatore

ANGELI, FABIO

Distribuzione geografica

Continente	#
NA - Nord America	13.616
EU - Europa	9.899
AS - Asia	921
SA - Sud America	7
Continente sconosciuto - Info sul continente non disponibili	4
AF - Africa	2
OC - Oceania	2
Totale	24.451

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	13.610
IT - Italia	6.077
UA - Ucraina	1.667
IE - Irlanda	824
VN - Vietnam	641
DE - Germania	531
SE - Svezia	370
GB - Regno Unito	320
CN - Cina	186
TR - Turchia	55
FR - Francia	27
FI - Finlandia	22
IN - India	21
BE - Belgio	16
AT - Austria	11
CZ - Repubblica Ceca	8
BR - Brasile	5
CA - Canada	5
NL - Olanda	5
RO - Romania	5
EU - Europa	4
ES - Italia	3
JP - Giappone	3
AU - Australia	2
CH - Svizzera	2
GR - Grecia	2
MY - Malesia	2
PH - Filippine	2
RS - Serbia	2
AM - Armenia	1
BG - Bulgaria	1
CL - Cile	1
CO - Colombia	1
EE - Estonia	1
EG - Egitto	1
HK - Hong Kong	1
HR - Croazia	1
IL - Israele	1
IQ - Iraq	1
KR - Corea	1
KZ - Kazakistan	1
LK - Sri Lanka	1
LU - Lussemburgo	1
MX - Messico	1
OM - Oman	1
PK - Pakistan	1
RU - Federazione Russa	1
SA - Arabia Saudita	1
SG - Singapore	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
ZA - Sudafrica	1
Totale	24.451

Salva come PNG Salva come JPEG

Città	#
Milan	4.625
Fairfield	2.751
Ashburn	1.775
Woodbridge	1.298
Seattle	1.085
Wilmington	1.035
Houston	1.023
Cambridge	937
Jacksonville	885
Dublin	810
Princeton	650
Rome	433
Ann Arbor	404
Chandler	397
Dong Ket	330
Nyköping	234
San Diego	221
Washington	200
London	96
Beijing	91
New York	78
Kocaeli	53
Prescot	27
Boardman	26
Norwalk	23
Helsinki	18
Redmond	17
Treviglio	17
Brussels	16
Chiswick	16
Acton	15
Kunming	14
Como	13
Hounslow	12
Redwood City	12
Hefei	11
Vienna	11
Boydton	10
Nanjing	10
Chennai	9
Varese	9
Brno	8
Olgiate Comasco	8
New Bedfont	7
Shanghai	7
Bergamo	6
Chicago	6
Jinan	6
Menlo Park	6
Pune	6
Guangzhou	5
Nanchang	5
San Genesio Ed Uniti	5
Zhengzhou	5
Bassano del Grappa	4
Hebei	4
Leawood	4
Paris	4
San Francisco	4
Shenyang	4
Stockholm	4
Toronto	4
Wuhan	4
Xian	4
Alleppey	3
Amsterdam	3
Esslingen am Neckar	3
Ferentino	3
Fuzhou	3
Greenwich	3
Islington	3
Lappeenranta	3
Lesmo	3
Phoenix	3
São Paulo	3
Tokyo	3
Atlanta	2
Belgrade	2
Berlin	2
Chongqing	2
Cologne	2
Edinburgh	2
Florence	2
Frankfurt am Main	2
Istanbul	2
Kuala Lumpur	2
Los Angeles	2
Manila	2
San Jose	2
San Polo	2
Shaoxing	2
Acqui Terme	1
Almaty	1
Athens	1
Bitonto	1
Bologna	1
Bolton	1
Borås	1
Boulder	1
Bratislava	1
Totale	19.892

Salva come PNG Salva come JPEG

Nome	#
Response to Is Vascular Morning Blood Pressure Surge in the Elderly Resistant to Antihypertensives and More Risky?	198
How can we use the results of ambulatory blood pressure monitoring in clinical practice?	179
Optimal Therapy in Hypertensive Subjects with Diabetes Mellitus	169
Circadian rhythm of pulse pressure in hypertension: Prognostic implications	165
Association between periodontal disease and left ventricle mass in essential hypertension	162
Simplifying the ECG Diagnosis of Left Ventricular Hypertrophy	153
Good news for beta-blockers in perioperative medicine	139
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus	130
Intensive Blood Pressure Lowering and Regression of Left Ventricular Hypertrophy	125
DAY-NIGHT RELATED EVENTS: NIGHTTIME BLOOD PRESSURE FALL AND MORNING BLOOD PRESSURE RISE	122
Microcirculation and left-ventricular hypertrophy	121
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke	119
Above Which Blood Pressure Level Does the Risk of Atrial Fibrillation Increase?	117
Sudden Cardiac Death in Hypertensive Patients	116
Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overview	113
Aggressive blood pressure reduction in patients at high vascular risk: Is it dangerous?	113
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation-the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study	113
Modernization and hypertension: is the link changing?	111
Hypertension and the J-curve phenomenon: implications for tight blood pressure control	110
The clinical significance of white-coat and masked hypertension	109
Interpretation of Ambulatory Blood Pressure Profile for Risk Stratification Keep It Simple	109
At the beginning of stiffening - Endothelial dysfunction meets "pulsology"	108
Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain	108
Adverse prognostic significance of new diabetes in treated hypertensive subjects	108
The optimal blood pressure target for patients with coronary artery disease	108
PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives	107
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study	106
How important is to reduce sodium and increase potassium in patients with hypertension?	105
Aggressive Blood Pressure Lowering Is Dangerous: The J-Curve Con Side of the Argument	104
Ambulatory blood pressure monitoring and prognosis in the management of essential hypertension	104
Neutrophil Count for the Identification of Postmenopausal Hypertensive Women at Increased Cardiovascular Risk	104
Pulse pressure affects the relationship between flow-mediated dilatation and cardiovascular risk	103
Cardiac Benefits of an Intensive Blood Pressure Control in Diabetes Mellitus	103
Very early initiation of statin therapy and mortality in patients with acute coronary syndrome	103
Does brachial pulse pressure predict coronary events?	102
Ambulatory blood pressure for cardiovascular risk stratification	102
Detrimental Effects of Hyperglycemia in Acute Coronary Syndromes: from Pathophysiological Mechanisms to Therapeutic Strategies	102
A Risk Score for Predicting 1-Year Mortality in Patients >= 75 Years of Age Presenting With Non-ST-Elevation Acute Coronary Syndrome	102
Echocardiographic left ventricular hypertrophy in hypertension: marker for future events or mediator of events?	101
White-coat hypertension in adults	101
The emerging role of high-density lipoprotein cholesterol in hypertension trials	100
Improved cardiovascular risk stratification by a simple ECG index in hypertension	100
Estimate of white-coat effect and arterial stiffness	99
Response to Role of Yin and Yang in Diurnal Blood Pressure Variation for Cardiovascular Disease	99
What to Do When Blood Pressure Is Between 130/80 and 139/89 mm Hg?	99
Aliskiren versus ramipril in hypertension	99
Is Hydrochlorothiazide More Effective on LVH in Nonresponders to Losartan Than in Those to Atenolol?	99
Hyperglycemia in acute coronary syndromes: From mechanisms to prognostic implications	99
Angiotensin-converting enzyme inhibitors	98
Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension	98
Early Invasive Versus Selectively Invasive Strategy in Patients With Non-ST- Segment Elevation Acute Coronary Syndrome: Impact of Age	97
Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects	97
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis	97
Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension Prognostic Implications	97
Electrocardiographic abnormalities of left ventricular repolarization: Prognostic implications in hypertensive post-menopausal women	97
Atrial fibrillation in hypertension - Predictors and outcome	96
Hypertension, inflammation and atrial fibrillation	96
Prognostic value of serial Electrocardiographic voltage and repolarization changes in essential hypertension: The HEART survey study	96
Day-to-day variability of electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive patients. Influence of electrode placement	96
Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions	95
Meta-analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension	95
Left Ventricular Hypertrophy and Coronary Artery Calcifications: A Dangerous Duet?	95
Compared with whom? Addressing the prognostic value of ambulatory blood pressure categories	95
Risk of stroke in white-coat hypertension: A multinational registry	95
Atrial Fibrillation and Mortality in Patients with Acute Myocardial Infarction: A Systematic Overview and Meta-analysis	94
Additive value of standard ECG for the risk prediction of hypertensive disorders during pregnancy	94
The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy	93
Clinical significance of the blood pressure changes from day to night	93
Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention	93
Neutrophil Count and Ambulatory Pulse Pressure as Predictors of Cardiovascular Adverse Events in Postmenopausal Women with Hypertension	93
Blood pressure lowering in diabetic patients	93
Atrial activation analysis by surface P wave and multipolar esophageal recording after cardioversion of persistent atrial fibrillation	93
Assessment of the optimal daily dose of valsartan in patients with hypertension, heart failure, or both	92
Natural history of hypertension subtypes	92
Renal dysfunction, coronary revascularization and mortality among elderly patients with non ST elevation acute coronary syndrome	92
Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment	92
Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?	92
Short- and long-term incidence of stroke in white-coat hypertension	92
Do angiotensin II receptor blockers increase the risk of myocardial infarction?	92
The Evolution and Refinement of Traditional Risk Factors for Cardiovascular Disease	92
Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis	91
Adverse prognostic significance of new diabetes in treated hypertensive subjects	91
New-onset diabetes, antihypertensive treatment, and outcome	91
New-onset diabetes in treated hypertensive patients	91
PROGNOSTIC VALUE OF URIC ACID IN RELATION TO DIFFERENT AMBULATORY BLOOD PRESSURE COMPONENTS IN THE ABP-INTERNATIONAL STUDY	90
Effects of barnidipine on blood pressure and left ventricular diastolic function in patients with hypertension and metabolic syndrome: A 12-week, open-label noncomparison study	90
Validation of the A&D UA-705 device for self-measurement of blood pressure according to the British Hypertension Society protocol	90
Clinical usefulness of ambulatory blood pressure monitoring	90
Prognostic value of lipoprotein fractions in essential hypertension	90
Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach	90
Diuretic Treatment of Hypertension	90
Angiotensin-converting enzyme inhibitors	89
Hypertension and Atrial Fibrillation Doubts and Certainties From Basic and Clinical Studies	89
European and US guidelines for arterial hypertension: similarities and differences	89
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials	89
Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: A meta-analysis	89
Validation of the A&D wrist-cuff UB-511 (UB-512) device for self-measurement of blood pressure	89
Improved performance of traditional ECG for diagnosis of left ventricular hypertrophy in hypertension	89
Tight Blood Pressure Control in Diabetes: Evidence-Based Review of Treatment Targets in Patients with Diabetes	89
Asymptomatic left ventricular systolic dysfunction in essential hypertension - Prevalence, determinants, and prognostic value	89
Totale	10.385

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	87.781
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	87.781

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	5.188	0	0	0	0	0	678	1.282	1.082	820	558	195	573
2020/2021	7.218	55	1.246	354	937	206	1.072	268	640	728	401	421	890
2021/2022	2.848	271	509	61	89	82	120	183	221	193	444	309	366
2022/2023	2.111	341	75	82	146	91	513	16	253	255	206	65	68
2023/2024	7.534	1.111	1.237	1.209	1.491	1.789	697	0	0	0	0	0	0
Totale													24.899